Traded as NASDAQ: CTSO Products CytoSorb Founded 1997 | Industry Critical care Headquarters New Jersey, United States Number of employees 52 | |
 | ||
Stock price CTSO (NASDAQ) US$ 5.30 +0.05 (+0.95%)7 Mar, 12:02 PM GMT-5 - Disclaimer Profiles | ||
Cytosorbents corporation ctso investorial
Cytosorbents Corporation is a publicly traded company (NasdaqCM: CTSO) located in Monmouth Junction, New Jersey. Cytosorbents has created a blood purification technology based on biocompatible, porous polymer beads that act like sponges in an attempt to remove harmful substances from the blood.
Contents
CytoSorb, the company's first product to market, received its CE mark approval in 2011.
CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency (DARPA) for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins. The US Army awarded the Company a $1.15 million small-business innovation research contract to evaluate the technology in burn and trauma.
Snnlive cytosorbents corporation
References
Cytosorbents Corporation Wikipedia(Text) CC BY-SA